Medtronic, Genzyme Lead US Orthopedic Biomaterials Market Due to High R&D Costs Limiting Competition 19/07/2017 iData Research The U.S. orthopedic biomaterials market is expected to increase to exceed $4.5 billion by 2023... Read More
